CN Patent

CN108069914A — 一种西里帕格晶型的制备方法

Assigned to Jiangsu Ai Kang Pharmaceutical Ltd By Share Ltd · Expires 2018-05-25 · 8y expired

What this patent protects

本发明的主要目的在于提供一种西里帕格晶型的制备方法，使用该方法制备的晶体，其X‑射线粉末衍射图在（2θ±0.2°）9.3°、9.7°、16.8°、20.6°和23.5°有特征峰，该法操作简便、溶残少、产品质量稳定、适合工业化大生产等优点。

USPTO Abstract

本发明的主要目的在于提供一种西里帕格晶型的制备方法，使用该方法制备的晶体，其X‑射线粉末衍射图在（2θ±0.2°）9.3°、9.7°、16.8°、20.6°和23.5°有特征峰，该法操作简便、溶残少、产品质量稳定、适合工业化大生产等优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN108069914A
Jurisdiction
CN
Classification
—
Expires
2018-05-25
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Ai Kang Pharmaceutical Ltd By Share Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.